Gene symbol: Lif

Organism: Rattus norvegicus

Summary: Enables leukemia inhibitory factor receptor binding activity. Involved in several processes, including negative regulation of angiogenesis; positive regulation of corticotropin secretion; and transdifferentiation. Located in extracellular space. Biomarker of brain ischemia and congestive heart failure. Orthologous to human LIF (LIF interleukin 6 family cytokine). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 60584 Ensembl:ENSRNOG00000007002 AllianceGenome:RGD:620865


GO Annotation


Category Term ID Term description
Process GO:0000003 Reproduction
Process GO:0000280 Nuclear division
Process GO:0001654 Eye development
Process GO:0001701 In utero embryonic development
Process GO:0001890 Placenta development
Process GO:0001892 Embryonic placenta development
Process GO:0001893 Maternal placenta development
Process GO:0001932 Regulation of protein phosphorylation
Process GO:0001934 Positive regulation of protein phosphorylation
Process GO:0001944 Vasculature development
Process GO:0001974 Blood vessel remodeling
Process GO:0002376 Immune system process
Process GO:0002682 Regulation of immune system process
Process GO:0002684 Positive regulation of immune system process
Process GO:0002761 Regulation of myeloid leukocyte differentiation
Process GO:0002763 Positive regulation of myeloid leukocyte differentiation
Process GO:0002791 Regulation of peptide secretion
Process GO:0002793 Positive regulation of peptide secretion
Process GO:0003006 Developmental process involved in reproduction
Process GO:0003339 Regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis
Process GO:0006355 Regulation of transcription, DNA-templated
Process GO:0006357 Regulation of transcription by RNA polymerase II
Process GO:0006468 Protein phosphorylation
Process GO:0006793 Phosphorus metabolic process
Process GO:0006796 Phosphate-containing compound metabolic process
Process GO:0006807 Nitrogen compound metabolic process
Process GO:0006955 Immune response
Process GO:0006996 Organelle organization
Process GO:0007049 Cell cycle
Process GO:0007154 Cell communication
Process GO:0007165 Signal transduction
Process GO:0007166 Cell surface receptor signaling pathway
Process GO:0007167 Enzyme-linked receptor protein signaling pathway
Process GO:0007259 Receptor signaling pathway via JAK-STAT
Process GO:0007260 Tyrosine phosphorylation of STAT protein
Process GO:0007275 Multicellular organism development
Process GO:0007399 Nervous system development
Process GO:0007417 Central nervous system development
Process GO:0007423 Sensory organ development
Process GO:0007517 Muscle organ development
Process GO:0007565 Female pregnancy
Process GO:0007566 Embryo implantation
Process GO:0008152 Metabolic process
Process GO:0008283 Cell population proliferation
Process GO:0008284 Positive regulation of cell population proliferation
Process GO:0008285 Negative regulation of cell population proliferation
Process GO:0009653 Anatomical structure morphogenesis
Process GO:0009790 Embryo development
Process GO:0009792 Embryo development ending in birth or egg hatching
Process GO:0009887 Animal organ morphogenesis
Process GO:0009888 Tissue development
Process GO:0009889 Regulation of biosynthetic process
Process GO:0009891 Positive regulation of biosynthetic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009966 Regulation of signal transduction
Process GO:0009967 Positive regulation of signal transduction
Process GO:0009968 Negative regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0010001 Glial cell differentiation
Process GO:0010468 Regulation of gene expression
Process GO:0010556 Regulation of macromolecule biosynthetic process
Process GO:0010557 Positive regulation of macromolecule biosynthetic process
Process GO:0010562 Positive regulation of phosphorus metabolic process
Process GO:0010564 Regulation of cell cycle process
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010628 Positive regulation of gene expression
Process GO:0010639 Negative regulation of organelle organization
Process GO:0010646 Regulation of cell communication
Process GO:0010647 Positive regulation of cell communication
Process GO:0010648 Negative regulation of cell communication
Process GO:0010720 Positive regulation of cell development
Process GO:0010817 Regulation of hormone levels
Process GO:0010948 Negative regulation of cell cycle process
Process GO:0010975 Regulation of neuron projection development
Process GO:0010976 Positive regulation of neuron projection development
Process GO:0014013 Regulation of gliogenesis
Process GO:0014015 Positive regulation of gliogenesis
Process GO:0016043 Cellular component organization
Process GO:0016310 Phosphorylation
Process GO:0016525 Negative regulation of angiogenesis
Process GO:0018108 Peptidyl-tyrosine phosphorylation
Process GO:0018193 Peptidyl-amino acid modification
Process GO:0018212 Peptidyl-tyrosine modification
Process GO:0019219 Regulation of nucleobase-containing compound metabolic process
Process GO:0019220 Regulation of phosphate metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0019538 Protein metabolic process
Process GO:0019827 Stem cell population maintenance
Process GO:0022008 Neurogenesis
Process GO:0022402 Cell cycle process
Process GO:0022414 Reproductive process
Process GO:0022603 Regulation of anatomical structure morphogenesis
Process GO:0023051 Regulation of signaling
Process GO:0023052 Signaling
Process GO:0023056 Positive regulation of signaling
Process GO:0023057 Negative regulation of signaling
Process GO:0030154 Cell differentiation
Process GO:0030155 Regulation of cell adhesion
Process GO:0030182 Neuron differentiation
Process GO:0030323 Respiratory tube development
Process GO:0030324 Lung development
Process GO:0030856 Regulation of epithelial cell differentiation
Process GO:0030858 Positive regulation of epithelial cell differentiation
Process GO:0031056 Regulation of histone modification
Process GO:0031058 Positive regulation of histone modification
Process GO:0031099 Regeneration
Process GO:0031100 Animal organ regeneration
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031326 Regulation of cellular biosynthetic process
Process GO:0031328 Positive regulation of cellular biosynthetic process
Process GO:0031344 Regulation of cell projection organization
Process GO:0031346 Positive regulation of cell projection organization
Process GO:0031399 Regulation of protein modification process
Process GO:0031401 Positive regulation of protein modification process
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032504 Multicellular organism reproduction
Process GO:0032879 Regulation of localization
Process GO:0032880 Regulation of protein localization
Process GO:0033043 Regulation of organelle organization
Process GO:0033135 Regulation of peptidyl-serine phosphorylation
Process GO:0033138 Positive regulation of peptidyl-serine phosphorylation
Process GO:0033139 Regulation of peptidyl-serine phosphorylation of STAT protein
Process GO:0033141 Positive regulation of peptidyl-serine phosphorylation of STAT protein
Process GO:0033628 Regulation of cell adhesion mediated by integrin
Process GO:0033630 Positive regulation of cell adhesion mediated by integrin
Process GO:0035019 Somatic stem cell population maintenance
Process GO:0035065 Regulation of histone acetylation
Process GO:0035066 Positive regulation of histone acetylation
Process GO:0035295 Tube development
Process GO:0036211 Protein modification process
Process GO:0040020 Regulation of meiotic nuclear division
Process GO:0042063 Gliogenesis
Process GO:0042127 Regulation of cell population proliferation
Process GO:0042325 Regulation of phosphorylation
Process GO:0042327 Positive regulation of phosphorylation
Process GO:0042509 Regulation of tyrosine phosphorylation of STAT protein
Process GO:0042531 Positive regulation of tyrosine phosphorylation of STAT protein
Process GO:0043009 Chordate embryonic development
Process GO:0043010 Camera-type eye development
Process GO:0043170 Macromolecule metabolic process
Process GO:0043408 Regulation of MAPK cascade
Process GO:0043409 Negative regulation of MAPK cascade
Process GO:0043410 Positive regulation of MAPK cascade
Process GO:0043412 Macromolecule modification
Process GO:0044057 Regulation of system process
Process GO:0044060 Regulation of endocrine process
Process GO:0044237 Cellular metabolic process
Process GO:0044238 Primary metabolic process
Process GO:0044703 Multi-organism reproductive process
Process GO:0044706 Multi-multicellular organism process
Process GO:0045595 Regulation of cell differentiation
Process GO:0045597 Positive regulation of cell differentiation
Process GO:0045637 Regulation of myeloid cell differentiation
Process GO:0045639 Positive regulation of myeloid cell differentiation
Process GO:0045649 Regulation of macrophage differentiation
Process GO:0045651 Positive regulation of macrophage differentiation
Process GO:0045685 Regulation of glial cell differentiation
Process GO:0045687 Positive regulation of glial cell differentiation
Process GO:0045765 Regulation of angiogenesis
Process GO:0045785 Positive regulation of cell adhesion
Process GO:0045786 Negative regulation of cell cycle
Process GO:0045835 Negative regulation of meiotic nuclear division
Process GO:0045893 Positive regulation of transcription, DNA-templated
Process GO:0045935 Positive regulation of nucleobase-containing compound metabolic process
Process GO:0045937 Positive regulation of phosphate metabolic process
Process GO:0045944 Positive regulation of transcription by RNA polymerase II
Process GO:0046697 Decidualization
Process GO:0046883 Regulation of hormone secretion
Process GO:0046887 Positive regulation of hormone secretion
Process GO:0046888 Negative regulation of hormone secretion
Process GO:0048144 Fibroblast proliferation
Process GO:0048145 Regulation of fibroblast proliferation
Process GO:0048146 Positive regulation of fibroblast proliferation
Process GO:0048285 Organelle fission
Process GO:0048286 Lung alveolus development
Process GO:0048468 Cell development
Process GO:0048513 Animal organ development
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048568 Embryonic organ development
Process GO:0048583 Regulation of response to stimulus
Process GO:0048584 Positive regulation of response to stimulus
Process GO:0048585 Negative regulation of response to stimulus
Process GO:0048608 Reproductive structure development
Process GO:0048609 Multicellular organismal reproductive process
Process GO:0048644 Muscle organ morphogenesis
Process GO:0048666 Neuron development
Process GO:0048699 Generation of neurons
Process GO:0048708 Astrocyte differentiation
Process GO:0048710 Regulation of astrocyte differentiation
Process GO:0048711 Positive regulation of astrocyte differentiation
Process GO:0048731 System development
Process GO:0048771 Tissue remodeling
Process GO:0048856 Anatomical structure development
Process GO:0048861 Leukemia inhibitory factor signaling pathway
Process GO:0048863 Stem cell differentiation
Process GO:0048869 Cellular developmental process
Process GO:0048880 Sensory system development
Process GO:0050730 Regulation of peptidyl-tyrosine phosphorylation
Process GO:0050731 Positive regulation of peptidyl-tyrosine phosphorylation
Process GO:0050767 Regulation of neurogenesis
Process GO:0050769 Positive regulation of neurogenesis
Process GO:0050789 Regulation of biological process
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050896 Response to stimulus
Process GO:0051046 Regulation of secretion
Process GO:0051047 Positive regulation of secretion
Process GO:0051048 Negative regulation of secretion
Process GO:0051049 Regulation of transport
Process GO:0051050 Positive regulation of transport
Process GO:0051051 Negative regulation of transport
Process GO:0051093 Negative regulation of developmental process
Process GO:0051094 Positive regulation of developmental process
Process GO:0051098 Regulation of binding
Process GO:0051101 Regulation of DNA binding
Process GO:0051128 Regulation of cellular component organization
Process GO:0051129 Negative regulation of cellular component organization
Process GO:0051130 Positive regulation of cellular component organization
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051174 Regulation of phosphorus metabolic process
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051240 Positive regulation of multicellular organismal process
Process GO:0051241 Negative regulation of multicellular organismal process
Process GO:0051246 Regulation of protein metabolic process
Process GO:0051247 Positive regulation of protein metabolic process
Process GO:0051252 Regulation of RNA metabolic process
Process GO:0051254 Positive regulation of RNA metabolic process
Process GO:0051321 Meiotic cell cycle
Process GO:0051445 Regulation of meiotic cell cycle
Process GO:0051447 Negative regulation of meiotic cell cycle
Process GO:0051459 Regulation of corticotropin secretion
Process GO:0051461 Positive regulation of corticotropin secretion
Process GO:0051716 Cellular response to stimulus
Process GO:0051726 Regulation of cell cycle
Process GO:0051783 Regulation of nuclear division
Process GO:0051784 Negative regulation of nuclear division
Process GO:0051960 Regulation of nervous system development
Process GO:0051962 Positive regulation of nervous system development
Process GO:0060041 Retina development in camera-type eye
Process GO:0060135 Maternal process involved in female pregnancy
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060284 Regulation of cell development
Process GO:0060290 Transdifferentiation
Process GO:0060341 Regulation of cellular localization
Process GO:0060425 Lung morphogenesis
Process GO:0060426 Lung vasculature development
Process GO:0060462 Lung lobe development
Process GO:0060463 Lung lobe morphogenesis
Process GO:0060541 Respiratory system development
Process GO:0060706 Cell differentiation involved in embryonic placenta development
Process GO:0060707 Trophoblast giant cell differentiation
Process GO:0060708 Spongiotrophoblast differentiation
Process GO:0060712 Spongiotrophoblast layer development
Process GO:0061061 Muscle structure development
Process GO:0061458 Reproductive system development
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0070372 Regulation of ERK1 and ERK2 cascade
Process GO:0070373 Negative regulation of ERK1 and ERK2 cascade
Process GO:0071704 Organic substance metabolic process
Process GO:0071840 Cellular component organization or biogenesis
Process GO:0072108 Positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis
Process GO:0072182 Regulation of nephron tubule epithelial cell differentiation
Process GO:0072307 Regulation of metanephric nephron tubule epithelial cell differentiation
Process GO:0072359 Circulatory system development
Process GO:0080090 Regulation of primary metabolic process
Process GO:0090087 Regulation of peptide transport
Process GO:0090276 Regulation of peptide hormone secretion
Process GO:0090277 Positive regulation of peptide hormone secretion
Process GO:0097696 Receptor signaling pathway via STAT
Process GO:0098727 Maintenance of cell number
Process GO:0120035 Regulation of plasma membrane bounded cell projection organization
Process GO:0140013 Meiotic nuclear division
Process GO:0150063 Visual system development
Process GO:1900180 Regulation of protein localization to nucleus
Process GO:1900182 Positive regulation of protein localization to nucleus
Process GO:1901342 Regulation of vasculature development
Process GO:1901343 Negative regulation of vasculature development
Process GO:1901564 Organonitrogen compound metabolic process
Process GO:1901674 Regulation of histone H3-K27 acetylation
Process GO:1901676 Positive regulation of histone H3-K27 acetylation
Process GO:1901983 Regulation of protein acetylation
Process GO:1901985 Positive regulation of protein acetylation
Process GO:1902105 Regulation of leukocyte differentiation
Process GO:1902107 Positive regulation of leukocyte differentiation
Process GO:1902531 Regulation of intracellular signal transduction
Process GO:1902532 Negative regulation of intracellular signal transduction
Process GO:1902533 Positive regulation of intracellular signal transduction
Process GO:1902680 Positive regulation of RNA biosynthetic process
Process GO:1903025 Regulation of RNA polymerase II regulatory region sequence-specific DNA binding
Process GO:1903046 Meiotic cell cycle process
Process GO:1903506 Regulation of nucleic acid-templated transcription
Process GO:1903508 Positive regulation of nucleic acid-templated transcription
Process GO:1903530 Regulation of secretion by cell
Process GO:1903531 Negative regulation of secretion by cell
Process GO:1903532 Positive regulation of secretion by cell
Process GO:1903706 Regulation of hemopoiesis
Process GO:1903708 Positive regulation of hemopoiesis
Process GO:1903829 Positive regulation of protein localization
Process GO:1905330 Regulation of morphogenesis of an epithelium
Process GO:1905332 Positive regulation of morphogenesis of an epithelium
Process GO:2000026 Regulation of multicellular organismal development
Process GO:2000181 Negative regulation of blood vessel morphogenesis
Process GO:2000241 Regulation of reproductive process
Process GO:2000242 Negative regulation of reproductive process
Process GO:2000677 Regulation of transcription regulatory region DNA binding
Process GO:2000696 Regulation of epithelial cell differentiation involved in kidney development
Process GO:2000698 Positive regulation of epithelial cell differentiation involved in kidney development
Process GO:2000756 Regulation of peptidyl-lysine acetylation
Process GO:2000758 Positive regulation of peptidyl-lysine acetylation
Process GO:2001141 Regulation of RNA biosynthetic process
Component GO:0005576 Extracellular region
Component GO:0005615 Extracellular space
Component GO:0005622 Intracellular anatomical structure
Component GO:0005737 Cytoplasm
Component GO:0005829 Cytosol
Component GO:0110165 Cellular anatomical entity
Function GO:0005102 Signaling receptor binding
Function GO:0005125 Cytokine activity
Function GO:0005126 Cytokine receptor binding
Function GO:0005146 Leukemia inhibitory factor receptor binding
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0008083 Growth factor activity
Function GO:0030545 Signaling receptor regulator activity
Function GO:0030546 Signaling receptor activator activity
Function GO:0048018 Receptor ligand activity
Function GO:0098772 Molecular function regulator activity

Pathway annotation


Category Term ID Term description
RCTM RNO-1280215 Cytokine Signaling in Immune system
RCTM RNO-168256 Immune System
RCTM RNO-449147 Signaling by Interleukins
RCTM RNO-6783589 Interleukin-6 family signaling
RCTM RNO-6788467 IL-6-type cytokine receptor ligand interactions
WikiPathways WP155 Adipogenesis
KEGG rno04060 Cytokine-cytokine receptor interaction
KEGG rno04550 Signaling pathways regulating pluripotency of stem cells
KEGG rno04630 JAK-STAT signaling pathway
KEGG rno04668 TNF signaling pathway

Expression profile of Lif in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 6.5554934
GSM2685202 MX2 tissue: Myocardium gender: female 6.5708685
GSM2685203 MX3 tissue: Myocardium gender: female 6.5763826
GSM2685204 MX4 tissue: Myocardium gender: male 6.4949894
GSM2685205 DZ1 tissue: Myocardium gender: male 6.5253077
GSM2685206 DZ2 tissue: Myocardium gender: male 6.3808208
GSM2685207 DZ3 tissue: Myocardium gender: female 6.3372345
GSM2685208 DZ4 tissue: Myocardium gender: female 6.410167
GSM2685209 JJ1 tissue: Myocardium gender: male 6.566366
GSM2685210 JJ2 tissue: Myocardium gender: female 6.696072
GSM2685211 JJ3 tissue: Myocardium gender: female 6.6496253
GSM2685212 JJ4 tissue: Myocardium gender: male 6.573203
GSM2685213 NG1 tissue: Myocardium gender: male 6.7659187
GSM2685214 NG2 tissue: Myocardium gender: female 6.62884
GSM2685215 NG3 tissue: Myocardium gender: male 6.7665257
GSM2685216 NG4 tissue: Myocardium gender: female 6.7783117
GSM2685217 YL1 tissue: Myocardium gender: male 6.8200464
GSM2685218 YL2 tissue: Myocardium gender: male 6.85216
GSM2685219 YL3 tissue: Myocardium gender: female 6.15691
GSM2685220 YL4 tissue: Myocardium gender: female 6.6433887
GSM2685221 QC1 tissue: Myocardium gender: male 6.797902
GSM2685222 QC2 tissue: Myocardium gender: male 7.149496
GSM2685223 QC3 tissue: Myocardium gender: female 6.400226
GSM2685224 QC4 tissue: Myocardium gender: female 6.5742574

ID GSE136833
Title Effects of lidocaine on the expression of rat spinal cord
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4058984 Control_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 2.753775589
GSM4058985 Control_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 2.629238919
GSM4058986 Control_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 2.706719722
GSM4058987 Lidocaine_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 2.998609602
GSM4058988 Lidocaine_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.083597061
GSM4058989 Lidocaine_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 2.883069963

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 2.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 8.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 25.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 4.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 1.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 2.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 2.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 1.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 4.680488
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 5.175782
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 4.883705
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 5.331748
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 4.730738
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 4.752728

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 0.279
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 0.378
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 0.319
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 0.141
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 0.443

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 4.16645431
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 5.547338608
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 5.026264008

ID GSE1616
Title Genomics of preconditioning
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM27484 APC_a (anesthetic-preconditioning, 1st replicate) 252.8
GSM27485 APC_b (anesthetic-preconditioning, 2nd replicate) 115.8
GSM27486 APC_c (anesthetic-preconditioning, 3rd replicate) 229.2
GSM27487 APC_d (anesthetic-preconditioning, 4th replicate) 44.2
GSM27488 APC_e (anesthetic-preconditioning, 5th replicate) 138.2
GSM27489 APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) 294.8
GSM27490 APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) 284.0
GSM27491 APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) 295.1
GSM27492 APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) 257.3
GSM27493 APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) 244.5
GSM27494 CTL_a (control, 1st replicate) 59.6
GSM27495 CTL_b (control, 2nd replicate) 241.1
GSM27496 CTL_c (control, 3rd replicate) 61.3
GSM27497 CTL_d (control, 4th replicate) 167.0
GSM27498 CTL_e (control, 5th replicate) 386.5
GSM27499 IPC_a (ischemic preconditioning, 1st replicate) 119.8
GSM27500 IPC_b (ischemic preconditioning, 2nd replicate) 40.1
GSM27501 IPC_c (ischemic preconditioning, 3rd replicate) 42.7
GSM27502 IPC_d (ischemic preconditioning, 4th replicate) 44.2
GSM27503 IPC_e (ischemic preconditioning, 5th replicate) 242.5
GSM27504 IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) 378.5
GSM27505 IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) 360.9
GSM27506 IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) 264.2
GSM27507 IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) 298.3
GSM27508 IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) 373.7
GSM27509 ISCH_a (ischemia, 1st replicate) 218.6
GSM27510 ISCH_b (ischemia, 2nd replicate) 244.0
GSM27511 ISCH_c (ischemia, 3rd replicate) 255.7
GSM27512 ISCH_d (ischemia, 4th replicate) 253.6
GSM27513 ISCH_e (ischemia, 5th replicate) 319.2

ID GSE1779
Title Effect of Isoflurane and LTM on basolateral amygdala
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM30790 baseline control 01 male, 275-300g 177.1
GSM30791 baseline control 02 male, 275-300g 140.5
GSM30792 baseline control 03 male, 275-300g 97.2
GSM30793 baseline control 04 male, 275-300g 110.5
GSM30794 baseline control 05 male, 275-300g 106.2
GSM30795 baseline control 06 male, 275-300g 111.0
GSM30796 baseline control 07 male, 275-300g 113.4
GSM30797 baseline control 08 male, 275-300g 117.2
GSM30798 baseline control 09 male, 275-300g 150.4
GSM30799 pain 01 122.1
GSM30800 pain 02 116.7
GSM30801 pain 03 264.7
GSM30802 pain 04 107.5
GSM30803 pain 05 132.9
GSM30804 FC 01 171.5
GSM30805 FC 02 129.1
GSM30806 FC 03 123.1
GSM30807 FC 04 104.5
GSM30808 FC 05 89.6
GSM30809 IFC 01 114.9
GSM30810 IFC 02 95.9
GSM30811 IFC 03 72.9
GSM30812 IFC 04 84.0
GSM30813 IFC 05 68.9
GSM99800 isoflurane 01 male, 275-300g 97.0
GSM99801 isoflurane 02 male, 275-300g 92.4
GSM99802 isoflurane 03 male, 275-300g 146.6
GSM99803 isoflurane 04 male, 275-300g 84.4
GSM99804 isoflurane 05 male, 275-300g 118.2

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 6.3746
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 4.9386
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 5.5717
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 7.8341
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 6.4312
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 5.5667
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 5.7123
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 5.9908
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 6.4478

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 3.92096
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 3.92327
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 3.6031
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 3.84759
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 4.34165
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 4.32741
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 3.85088
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 4.26852
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 3.65472
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 3.9686
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 3.43751
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 4.227
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 4.15512
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 4.02424
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 3.47923
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 3.81282

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.660695
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 6.073301
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.790245
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.852406
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.954402
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.791474
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 6.154109
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.870339
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.879573
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.965656
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 6.011575
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.519789
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.79929
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.826039
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 6.177967
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.850944
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.735648
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.768472
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.849113
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.809864
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.574877
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.894046
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.808152
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.644835
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.789424
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.8529
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.904071
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.578777
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.938119
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.843968
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.43042
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.913181
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.671198
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.95204
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 6.170557
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.720086
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.71944
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.775717
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.815891
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.627389
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.869879
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.717207
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.379808
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.715536
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.702515

ID GSE244436
Title Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7816143 Liver, Control for SevoAnes tissue: liver genotype: wild type treatment: Control for SevoAnes 0.0
GSM7816144 Liver, Anesthetized with sevoflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h 0.0
GSM7816145 Liver, Control for DesAnes tissue: liver genotype: wild type treatment: Control for DesAnes 0.0
GSM7816146 Liver, Anesthetized with desflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h 0.517439

ID GSE2982
Title Effect of inhaled anesthetic to cultured cortical neurons
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM61779 Cell Culture Exposure (control1) Cy3 label;Cy5; -0.137
GSM61796 Cell Culture Exposure (control2) Cy3; Cy5 -0.0392
GSM61797 Cell Culture Exposure (control3) Cy3; Cy5 -0.146
GSM61798 Cell Culture Exposure (1MAC Halo1) Cy3; Cy5 -0.26
GSM61799 Cell Culture Exposure (1MAC Halo2) Cy3; Cy5 -0.125
GSM61800 Cell Culture Exposure (1MAC Halo3) Cy3; Cy5 0.00834
GSM61801 Cell Culture Exposure (3MAC Halo1) Cy3; Cy5 -0.155
GSM61802 Cell Culture Exposure (3MAC Halo2) Cy3; Cy5 -0.0593
GSM61803 Cell Culture Exposure (3MAC Halo3) Cy3; Cy5 -0.0418
GSM61804 Cell Culture Exposure (3MAC ISO1) Cy3; Cy5 -0.0811
GSM61805 Cell Culture Exposure (3MAC ISO2) Cy3; Cy5 -0.046
GSM61806 Cell Culture Exposure (3MAC ISO3) Cy3; Cy5 -0.0254

ID GSE359
Title Isoflurane Single Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5120 Isoflurane single exposure control-1 99.3
GSM5121 Isoflurane single exposure control-2 79.2
GSM5122 Isoflurane single exposure control-3 55.9
GSM5124 Isoflurane single exposure 1 hr-1 73.4
GSM5126 Isoflurane single exposure 1 hr-2 41.7
GSM5127 Isoflurane single exposure 2 hr-1 37.6
GSM5130 Isoflurane single exposure 2 hr-2 73.1
GSM5131 Isoflurane single exposure 2 hr-3 59.5

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.655135658
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.773510427
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.871656504
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.653476426
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.742768315
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.797558376
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 4.534932665
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.541099298
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.497655544
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.581873928
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.749074222
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.690819757
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 3.666116721
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.02068333
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.591661461
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.873804862
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 4.304475416
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 3.889122807
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 4.048659623
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.9221195
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.999411129
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.962990617
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.80719644
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 4.123483186

ID GSE53897
Title Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1303240 DRG RVM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.574584
GSM1303241 DRG RVM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.731198
GSM1303242 DRG RVM3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.60876
GSM1303243 DRG RVM7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.766808
GSM1303244 DRG RVOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.807312
GSM1303245 DRG RVOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.762591
GSM1303246 DRG RVOx5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.567327
GSM1303247 DRG RVOx7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.583958
GSM1303248 DRG RVS4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.700549
GSM1303249 DRG RVS5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.690745
GSM1303250 DRG RVS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.655615
GSM1303251 DRG RVS7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.535343
GSM1303252 DRG RSM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.60547
GSM1303253 DRG RSM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.828945
GSM1303254 DRG RSM4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.574557
GSM1303255 DRG RSM5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.671997
GSM1303256 DRG RSOx1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.62897
GSM1303257 DRG RSOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.652456
GSM1303258 DRG RSOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.597711
GSM1303259 DRG RSOx4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.716756
GSM1303260 DRG RSS1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.677764
GSM1303261 DRG RSS2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.633423
GSM1303262 DRG RSS3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.71319
GSM1303263 DRG RSS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.616045

ID GSE55573
Title Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1339443 Mock skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 104.1852
GSM1339444 EA (electroacupuncture) skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 104.2317

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 40.71711792
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 57.23450401
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 166.2591265
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 68.01870635
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 41.03352454
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 12.66967998
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 66.23786219
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 61.83293303
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 72.26446541
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 73.33184189
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 31.9027153
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 135.1559707
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 81.44944455
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 59.74162331

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.655135658
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.773510427
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.871656504
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.653476426
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.742768315
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.797558376
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 4.534932665
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.541099298
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.497655544
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.581873928
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.749074222
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.690819757
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 3.666116721
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.02068333
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.591661461
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.873804862
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 4.304475416
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 3.889122807
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 4.048659623
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.9221195
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.999411129
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.962990617
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.80719644
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 4.123483186
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 40.71711792
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 57.23450401
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 166.2591265
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 68.01870635
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 41.03352454
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 12.66967998
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 66.23786219
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 61.83293303
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 72.26446541
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 73.33184189
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 31.9027153
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 135.1559707
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 81.44944455
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 59.74162331

ID GSE752
Title Halothane/Isoflurane Repetitive Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5082 Control 1 13.3
GSM5084 Control 2 20.6
GSM5085 Control 3 16.2
GSM5086 Control 4 80.8
GSM5087 Control 5 23.5
GSM5090 Control 6 54.7
GSM5105 Control 7 59.1
GSM5106 Control 8 77.1
GSM5107 Control 9 55.6
GSM5108 Halothane 10 exposure-1 43.8
GSM5109 Halothane 10 exposures-2 30.3
GSM5110 Halothane 10 exposures-3 14.0
GSM5111 Halothane 5 exposures-1 39.5
GSM5112 Halothane 5 exposures-2 25.2
GSM5113 Halothane 5 exposures-3 12.3
GSM5114 Isoflurane 10 exposures-1 17.2
GSM5115 Isoflurane 10 exposures-2 66.3
GSM5116 Isoflurane 10 exposures-3 12.7
GSM5117 Isoflurane 5 exposures-1 46.7
GSM5118 Isoflurane 5 exposures-2 68.3
GSM5119 Isoflurane 5 exposures-3 15.7
GSM11379 Control 10 31.1
GSM11380 Control 11 45.3
GSM11381 Control 12 15.4

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 11.6258
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 1.12078